8-K: Current report filing
Published on June 10, 2014
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 6, 2014
NEOGENOMICS, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 001-35756 | 74-2897368 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 12701 Commonwealth Drive, Suite 9, Fort Myers, Florida |
33913 | |
| (Address of principal executive offices) | (Zip Code) |
(239) 768-0600
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07. | Submission of Matters to a Vote of Security Holders. |
On June 6, 2014, NeoGenomics, Inc., a Nevada corporation (the Company), held an annual meeting of its stockholders (the 2014 Annual Meeting). At the 2014 Annual Meeting, a total of 34,921,577 shares of the Companys common stock, par value $0.001 per share (Common Stock), were present or represented by proxy at the meeting, representing approximately seventy percent (70%) of the outstanding Common Stock as of April 15, 2014, the record date for the 2014 Annual Meeting.
At the 2014 Annual Meeting, one (1) proposal was submitted for a vote of the Companys stockholders and the related results are as follows:
| (1) | The election of six (6) directors to the Companys board of directors for terms until the next succeeding annual meeting of stockholders. The stockholders elected six (6) directors pursuant to a plurality vote, by the following votes: |
| Director |
Votes For | Votes Withheld | Votes Against | Broker Non-Votes | ||||||||||||
| Douglas M. VanOort |
30,778,889 | 4,142,688 | 0 | 0 | ||||||||||||
| Steven C. Jones |
29,255,928 | 5,665,649 | 0 | 0 | ||||||||||||
| Michael T. Dent |
16,837,383 | 18,084,194 | 0 | 0 | ||||||||||||
| Kevin C. Johnson |
32,096,828 | 2,824,749 | 0 | 0 | ||||||||||||
| Raymond R. Hipp |
31,086,636 | 3,834,941 | 0 | 0 | ||||||||||||
| William Robison |
32,558,524 | 2,363,053 | 0 | 0 | ||||||||||||
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NEOGENOMICS, INC. | ||
| By: | /s/ Steven C. Jones |
|
| Steven C. Jones | ||
| Executive Vice President Finance | ||
Date: June 10, 2014
- 3 -